Personalized Ventilator Settings for Patients on ECMO

This study is looking at how to best set ventilators for patients with severe lung injury, called Acute Respiratory Distress Syndrome (ARDS), who are also on Extracorporeal Membrane Oxygenation (ECMO), sometimes called a heart-lung machine. While ventilators help you breathe, they can sometimes cause more lung damage. ECMO helps reduce this damage, but doctors aren't sure of the best ventilator settings to use while on ECMO. This study will compare a personalized ventilator setting, called Personalized Positive End-Expiratory Pressure (PEEP), to the usual ventilator settings. Researchers will measure inflammation (IL-6 and sRAGE), breathing effectiveness, and lung mechanics to see if personalized settings reduce lung injury. You may be able to join if you are 18 or older and meet other specific criteria.

Study design
This is an interventional study planning to enroll 62 participants. Participants will be randomly assigned to receive either personalized ventilator settings or standard ventilator settings.
What's involved
Participants will have measurements taken at the start of the study, then at 24, 48, and 72 hours after enrollment, and at the end of their ECMO treatment.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed until the end of their ECMO run.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07673250

Personalized Ventilator Settings for Patients on ECMO

Not Yet Recruiting
NAAges 18+InterventionalTreatment
University of California, San Diego
~62 participants
Updated 2026-08-06 on ClinicalTrials.gov
What's tested:Personalized Positive End-Expiratory Pressure (PEEP)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Biomarker outcome (IL-6)
Measured over Baseline at enrollment, 24±12 hours post enrollment, 48±12 hours post enrollment.
+2 more outcomes measured
Acute Respiratory Distress Syndrome (ARDS)
Extracorporeal Membrane Oxygenation
Respiratory Failure Patients Treated With ECMO
Respiratory Failure, ICU
Ventilator Induced Lung Injury
1 sites across 1 states
California1
  • Mazen F Odish, M.D. · PRINCIPAL_INVESTIGATOR · University of California, San Diego

Opens a ready-to-send draft in your own email app — review before sending.

  • Biomarker outcome (IL-6)Baseline at enrollment, 24±12 hours post enrollment, 48±12 hours post enrollment.

    IL-6 is a marker of systemic inflammation, previously used in studies of ECMO and ARDS.

  • Respiratory gas exchange (dead space, oxygenation).Baseline at enrollment, 24±12 hours post enrollment, 48±12 hours post enrollment.

    Arterial oxygenation (mmHg) will be assessed with the arterial blood gas. Deadspace fraction (unitless) will be calculated by the end-title CO2 monitoring.

  • Respiratory mechanics (compliance of the respiratory system)Baseline at enrollment, 24±12 hours post enrollment, 48±12 hours post enrollment.

    Compliance (ml/cmH2O) and tidal volumes (milliliters) will be measured by the ventilator.